Xiaohan Chi's Homepage

Welcome to my homepage! I am a third-year PhD candidate in the Department of Biostatistics at The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), co-advised by Dr. Ruitao Lin and Dr. Ying Yuan. Before joining MD Anderson, I obtained both my MS and BS degrees from Shanghai Jiao Tong University (SJTU), advised by Dr. Zhangsheng Yu.

My current research interests lie in Bayesian clinical trial design, covariate adjustment and causal inference.

MS, Shanghai Jiao Tong University, 2022
BS, Shanghai Jiao Tong University, 2019

2025

Yeboa DN, Li J, Lin R, …, Chi X, … (2025) Therapy, Safety, and Logistics of Preoperative vs Postoperative Stereotactic Radiation Therapy: A Preliminary Analysis of a Randomized Clinical Trial. JAMA Oncology.

Chi X, Lin R, and Yuan Y. (2025). COCA: a randomized Bayesian design integrating dose optimization and component contribution assessment for combination therapies. Biometrics. 81(2):ujaf077.

Wang Y, Chi X, and Lin R. (2025). Three-Outcome Dual-Criterion Randomized Phase II Clinical Trial Design. The New England Journal of Statistics in Data Science.

2024

Chi X, Yuan Y, Yu Z, and Lin R. (2024). A generalized calibrated Bayesian hierarchical modeling approach to basket trials with multiple endpoints. Biometrical Journal. 66(2): 2300122.

Dasgupta P, Dagher S, Chi X, Soomro Z, Wathoo C, Lin R, Wintermark M, Chen M, Puduvalli VK, and Majd NK. (2024). Biom-32. Genomic determinants of diffusely infiltrative gliomatosis cerebri pattern. Neuro-Oncology. 26(Supplement_8): viii26.

2022

Chi X, Yu Z, and Lin R. (2022). BOB: Bayesian optimal design for biosimilar trials with co-primary endpoints. Statistics in Medicine. 41(26): 5319 – 5334.

1. Third Place of 2025 JSM Biopharmaceutical Student Paper Awards.
   Awarded project: BOP2-Comb.
2. Second Place of 2023 JSM Biopharmaceutical Student Paper Awards.
   Awarded project: the Generalized Calibrated Bayesian Hierarchical Modeling Approach (GCBHM).
3. Honorable Mention Winner of 2022 JSM Biopharmaceutical Student Paper Awards.
   Awarded project: the Bayesian Optimal Design for Biosimilar Trials (BOB).